Legalization of Marijuana (Support Legalization of Marijuana for medical and recreation use)
SAMPLE ANNOTATED BIBLIOGRAPHY ENTRY This example uses the MLA format, 8th Edition. (You must also have a running header, not shown here. You MUST consult the Purdue Owl for page format guidelines as well as citations.)
Your Name
Dr. Randall Watson
English 1302
25 June 2017
Legalizing Marijuana for Medical Use: An Annotated Bibliography
Backes, Michael. Cannabis Pharmacy: The Practical Guide to Medical Marijuana. New
York, Black Dog & Leventhal, 2014.
Author Michael Backes, is a respected expert in his field and head of research at
California’s first research based medical cannabis collective, Abatin Wellness
Center. The book explains how cannabis acts in the human body including how it
affects the endocannabinoid system, which plays a large role in medical use.
Backes has prepared a guide for 29 illnesses to which medical marijuana can be
effective in treating ailments such as chronic pain, multiple sclerosis, Alzheimer’s
disease, and chemotherapy associated nausea, to name a few. The book
includes dosage control and cannabis varieties, written clearly for practical use
and understanding. To lend credibility, the book includes a foreword by Harvard
educated physician and alternative medicine guru Andrew Weil.
Caffarel, María M., et al. "Cannabinoids Reduce Erbb2-Driven Breast Cancer
Progression through Akt Inhibition." Molecular Cancer, vol. 9, Jan. 2010, pp.
196-206. EBSCOhost.
The authors and researchers at BioMed Central conducted a research study to
test the effectiveness of cannabinoids on reducing ErbB2-driven breast cancer
through Akt inhibition. ErbB2-positive breast cancer is aggressive and has a low
chance of responding to traditional therapies. Specific therapies which target the
phenotypes do exist, however the patients are likely to relapse, which is why
they seek alternate therapies. In this study, histological analysis of MMTV-mice
indicated that when delta 9-tetrahydrocannibol was used as a therapy, cancer
cell proliferation was inhibited and cancer cell apoptosis was induced. The study
found that 91% of ErbB2-positive tumors expressed the cannabinoid CB2
receptors. In relation to the FDA’s need for research, this study shows valid
evidence to support that cannabinoids are effective cancer based therapies.
“Cannabinoids Testimonials.” Cancer Survivors Network, csn.cancer.org/node/283635.
Accessed 30 Apr. 2017.
The American Cancer Society has dedicated a page to cancer survivors and their
testimonials on cannabinoids. Some have posted links to research based studies
and journals, while others simply share testimonials. The most powerful being a
woman who claims she was diagnosed with stage 4 cancer and given 6-9 months
to live back in 2010. She attributes self-treatment of cannabis to being alive and
scans showing no progression of the disease. While testimonials cannot replace
clinical trials, it is important to look at success stories of in palliative care patients
such as this and relate them to the medicinal benefits of marijuana because it is
the closest thing to human testing that currently exists.
Dougherty, Elizabeth. “Medicine Gone Rogue.” Harvard Medical School, 6 July 2016,
dbmi.hms.harvard.edu/news/medicine-gone-rogue. Accessed 30 Apr. 2017.
The authors, researchers, and engineers at Harvard Medical School collaborated
to discuss Rogue Therapeutics which is a new model of medicine intended to
challenge outdated, conventional wisdom. The unconventional therapies include
genetic testing, bionic pancreas’, and of course, cannabis therapy. Precision
medicine panelists including rogues and traditionalists discuss the possible
consequences that legalization will have given its lack of regulation by the FDA.